Anavex Life Sciences Corp (AVXL)

[falconer66a]

'Dead money,' is it?

Barchart (https://www.barchart.com/stocks/quotes/AVXL/interactive-chart) plots the share prices of AVXL shares since they appeared, in January 2007, when it opened around $12.33. Shot to about $22 in February 2008. In February 2011 around $17.23.

Downhill from there to a low of about $0.33 in December of 2014. Let's see the 'returns' (paper numbers) for an AVXL purchase in January 2015 at $0.75. Today, AVXL closed at $4.46.

It's about 94 months from January 2015, to now, to October 2020; 7.83 years. In that period, an AVXL share has increased from $0.33 to $4.46, a 13.51x increase. That's an increase of 1351%.

I'll take that kind of "dead money" any day. If anyone can find another equity that will increase that much in 7.83 years, let me know of it. I'd be delighted to let my dollars be 'dead' for that time, with that final value.

Of course, what will AVXL be worth two years (not 7.83 yrs) after regulatory approval for sales and therapeutic usages for is gained for the ANAVEX drug? Let me punch this in.

Imagine that someone, today, bought $1000 of AVXL shares, at $4.46. Then, in seven years, in 2027, the share price value has increased 13.51x. That's a value of $13,510.00; at a share price of $4.46 x 13.51 = $60.25.

Anyone think that when Anavex is able to sell blarcamesine to tens of millions of people across the globe (in, say, five years) the share price will be around $60? Ha. Add at least another digit.

AVXL is "dead money," right? I'm glad to own a thousand 'dead' shares or so. They'll 'liven up' some day. For me, worth the wait.